Glaucoma Therapeutics Market PPT 2022: Size, Growth, Demand and Forecast till 2027

1
Global Glaucoma Therapeutics Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Glaucoma Therapeutics Market Research
Report 2022-2027 According to the latest report
by IMARC Group, titled "Glaucoma Therapeutics
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast
2022-2027," the global glaucoma therapeutics
market size reached US 7 Billion in
2021. Glaucoma is an ocular disorder that
damages the optic nerve of the patient. The
structural changes in the optic nerves are
usually caused by the abnormally high intraocular
pressure (IOP) due to the extra build-up of fluid
in the front part of the eyes. This condition can
often lead to vision loss and permanent blindness
in progressive cases. Numerous medications and
therapies are prescribed to patients with
glaucoma in order to avoid complete vision loss.
Eye drops that belong to the class of
beta-blockers, alpha agonists, prostaglandins and
cholinergic are usually prescribed to reduce the
production of fluid in the eyes. These drops can
then be followed by conventional or laser
surgeries for effective results. In several
cases, a combination of both approaches is
utilized for the treatment of glaucoma. Request
for a PDF sample of this report
https//www.imarcgroup.com/glaucoma-therapeutics-m
arket/requestsample

4
Report Description and Highlights
Report Description
Global Glaucoma Therapeutics Market Trends The
market is primarily driven by the increasing
occurrence of glaucoma on the global level. This
can be attributed to the rising number of
patients who have diabetes due to their shifting
lifestyle patterns and a lack of physical
activities. This, along with the increasing
geriatric population that is more susceptible to
chronic ocular disorders, is providing a thrust
to the market growth. Along with this, there has
been a growing preference for the adoption of
laser glaucoma surgeries among the patients as
well as the healthcare professionals on account
of the successful outcomes of this procedure.
Multiple professionals are also prescribing
combination therapies for the treatment of
glaucoma that involves the use of polymer-based
contact lenses, drug-eluting punctal plugs,
implantable extended-release devices,
microneedle-injection devices and micro-dosing
technologies. Coupled with the increasing
number of awareness programs conducted by
multiple organizations to spread awareness
regarding the availability of effective glaucoma
therapeutics, this is creating a positive outlook
for the market. Some of the other factors
contributing to the market growth include the
continual research and development (RD)
activities to introduce innovative therapeutics
and the improving healthcare infrastructure
across the globe, especially in developing
economies.

5
Report Description and Highlights
Report Description
Looking forward, IMARC Group expects the market
is expected to grow at a CAGR of 6.52 during
2022-2027. View Report TOC, Figures and Tables
https//www.imarcgroup.com/glaucoma-therapeutics-m
arket

6
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Drug Class
• Prostaglandin Analogs
• Beta Blockers
• Alpha Adrenergic Agonists
• Carbonic Anhydrase Inhibitors
• Combination Drugs
• Others
•  
• Breakup by Indication
• Open Angle Glaucoma
• Angle Closure Glaucoma
• Others
• Breakup by End User
• Hospitals
• Ophthalmic Clinics

7
Report Description and Highlights
Report Description

• Ambulatory Surgery Centers
• Others
•  
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

8
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Aerie Pharmaceuticals Inc
• Allergan Plc
• Bausch Lomb Incorporated (Bausch Health
  Companies Inc.)
• Inotek Pharmaceuticals Corp
• Merck Co. Inc
• Novartis AG
• Pfizer Inc
• Santen Pharmaceutical Co. Ltd
• SIFI S.p.A
• Teva Pharmaceutical Industries Ltd
•  

9
Key Questions Answered in the Report
Report Description

• How has the global glaucoma therapeutics market
  performed so far and how will it perform in the
  coming years?
• What has been the impact of COVID-19 on the
  global glaucoma therapeutics market?
• What are the key regional markets?
• What is the breakup of the market based on the
  drug class?
• What is the breakup of the market based on the
  indication?
• What is the breakup of the market based on the
  end user?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global glaucoma
  therapeutics market and who are the key players?
• What is the degree of competition in the
  industry?
•  

10
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Glaucoma Therapeutics
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

11
Table of Contents
Report Description
6    Market Breakup by Drug Class    6.1  
 Prostaglandin Analogs        6.1.1 Market
Trends        6.1.2 Market Forecast    6.2  
 Beta Blockers        6.2.1 Market Trends     
  6.2.2 Market Forecast    6.3    Alpha
Adrenergic Agonists        6.3.1 Market Trends 
      6.3.2 Market Forecast    6.4    Carbonic
Anhydrase Inhibitors        6.4.1 Market
Trends        6.4.2 Market Forecast     6.5  
 Combination Drugs        6.5.1 Market Trends 
      6.5.2 Market Forecast Click here to visit
the complete table of content with list of
figures and tables https//www.imarcgroup.com/gla
ucoma-therapeutics-market/toc

12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
14
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
15

Contact Us